AUDIO-Wake up and think about my prostate cancer in 15 years

November 13, 2007

thermo.jpgPatients beware: A lawyer is running the world’s biggest drugmaker, Pfizer, while an efficiency expert is leading Merck.

And that means one thing — developing treatments for your ailment of tomorrow is not at the top of their list, according  to Thermo Fisher CEO Marijn Dekkers. Instead, major drugmakers weighed down with regulatory and legal issues are turning to new CEOs who don’t own a lab coat to steer them through these rocky waters.

It’s a short-sighted move, in his opinion, that puts another hurdle in front of their pursuit to discover new medicines.  

 

No comments so far

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/